TAM
ELOS

Telluride Asset Management’s Syneron Medical Ltd ELOS Stock Holding History

Telluride Asset Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,630
Closed -$132K – 375
2014
Q1 		$132K Buy
+10,630
New +$126K 0.11% 203

Other funds holding ELOS

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HC
Hourglass Capital Houston, Texas $508M AUM 32.5% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Telluride Asset Management's ELOS Position: Q2 2014 in Review

Telluride Asset Management sold out of Syneron Medical Ltd (ELOS) in Q2 2014, closing a stake of 10,630 shares — an estimated $132K sold.

Telluride Asset Management first reported a position in ELOS in Q1 2014 and held it in 1 quarter. The position peaked at $132K in Q1 2014. 61 funds tracked by Wall St. Rank hold ELOS as of Q2 2014.

  • Telluride Asset Management reported no remaining Syneron Medical Ltd position as of Q2 2014 after selling out during the quarter.
  • Telluride Asset Management sold 10,630 Syneron Medical Ltd shares in Q2 2014, an estimated $132K.
  • Telluride Asset Management first reported a position in Syneron Medical Ltd in Q1 2014 and held it in 1 quarter.
  • Telluride Asset Management's Syneron Medical Ltd position peaked at $132K in Q1 2014.
  • 61 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2014.

Based on Telluride Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.